Supporting Education & Research
We focus to continuously develop new specialties, new treatments, and invest in medical innovations that bring a brighter future. In addition to this, we are constantly committed to activities and initiatives within disease communities which support awareness and better research in areas of need, particularly within rare diseases.

Arrigo Prize: Committed to excellence in research
Established in 2000 in memory of Arrigo Recordati, this international recognition aims to promote scientific research. The prize awards €100,000 to a scientist who has particularly stood out for formulating an innovative research project. The winner is selected by an independent panel formed of global experts.
The 2022 edition, open to young researchers from anywhere in the world, was dedicated to the promotion and recognition of excellence in research on pituitary disorders. The prize was awarded to Dr Sabrina Chiloiro for her project on the role of the immune microenvironment in growth hormone (GH) secreting pituitary tumours. The award ceremony took place in Milan on 23 May 2022 during the European Congress of Endocrinology.
The 2024 edition is currently open, with pre-selection application period from June 1st – October 31st 2023, and is dedicated to the promotion and recognition of excellence in research within paediatric oncology, specifically neuroblastoma.

Shining a light on the burden of a rare disease like
Cushing’s syndrome
This is Cushing is an award-winning* global awareness campaign which aims to spread education on Cushing’s Syndrome. The campaign was designed together with the award-winning photographer Stefano Schirato and Federico II University of Naples Full Professors of Endocrinology Annamaria Colao and Rosario Pivonello to capture a moment in time of someone living with Cushing’s Syndrome.
Cushing’s Syndrome is a rare endocrine disorder caused by a chronic exposure to excessive levels of cortisol affecting less than 1 in 10,000 people in the European Union, which is equivalent to fewer than 51,000 patients. The disease is associated with significant morbidity and mortality due to cardiovascular and metabolic complications. In addition to the physical features, psychiatric manifestations are also a significant part of the disease which drastically affect patients’ quality of life.
*Winner of the 2023 PMEA Award for Patient Centricity. Read more.

Filling the educational gap in rare diseases
- Recordati Rare Diseases Foundation aims to organise training on rare diseases to improve diagnosis and spread currently available knowledge on therapeutic options.
- The organisation promotes scientific sharing of experience and knowledge between centre of expertise and specialists across the globe.
- Every year, the Foundation proposes tailored face to face courses that aim to provide physicians, worldwide, with clinically useful and the most up-to-date information concerning current knowledge and recommendations for care.
- The Foundation has delivered over 70 courses to over 3000 healthcare professionals since its creation.